Pzena Investment Management’s Cardinal Health CAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-664,657
| Closed | -$65.3M | – | 160 |
|
|
2024
Q2 | $65.3M | Buy |
664,657
+3,593
| +0.5% | +$366K | 0.23% | 64 |
|
|
2024
Q1 | $74M | Sell |
661,064
-499,565
| -43% | -$53.9M | 0.25% | 64 |
|
|
2023
Q4 | $117M | Sell |
1,160,629
-558,043
| -32% | -$55.4M | 0.44% | 44 |
|
|
2023
Q3 | $149M | Sell |
1,718,672
-167,817
| -9% | -$15.2M | 0.64% | 39 |
|
|
2023
Q2 | $178M | Sell |
1,886,489
-226,553
| -11% | -$19.1M | 0.76% | 40 |
|
|
2023
Q1 | $160M | Sell |
2,113,042
-434,510
| -17% | -$32.8M | 0.69% | 40 |
|
|
2022
Q4 | $196M | Sell |
2,547,552
-183,203
| -7% | -$13.9M | 0.87% | 35 |
|
|
2022
Q3 | $182M | Sell |
2,730,755
-164,887
| -6% | -$10.5M | 0.9% | 34 |
|
|
2022
Q2 | $151M | Sell |
2,895,642
-77,737
| -3% | -$4.42M | 0.68% | 40 |
|
|
2022
Q1 | $169M | Sell |
2,973,379
-10,982
| -0.4% | -$588K | 0.64% | 42 |
|
|
2021
Q4 | $154M | Buy |
2,984,361
+27,925
| +0.9% | +$1.37M | 0.58% | 43 |
|
|
2021
Q3 | $146M | Sell |
2,956,436
-6,367
| -0.2% | -$345K | 0.58% | 45 |
|
|
2021
Q2 | $169M | Sell |
2,962,803
-14,090
| -0.5% | -$823K | 0.66% | 42 |
|
|
2021
Q1 | $181M | Sell |
2,976,893
-223,698
| -7% | -$12.3M | 0.73% | 38 |
|
|
2020
Q4 | $171M | Buy |
3,200,591
+94,710
| +3% | +$4.91M | 0.81% | 38 |
|
|
2020
Q3 | $146M | Buy |
3,105,881
+101,472
| +3% | +$5.21M | 0.91% | 38 |
|
|
2020
Q2 | $157M | Sell |
3,004,409
-47,749
| -2% | -$2.46M | 1.02% | 35 |
|
|
2020
Q1 | $146M | Sell |
3,052,158
-948,239
| -24% | -$49.2M | 1.11% | 34 |
|
|
2019
Q4 | $202M | Buy |
4,000,397
+332,713
| +9% | +$17.2M | 0.94% | 37 |
|
|
2019
Q3 | $173M | Buy |
3,667,684
+22,986
| +0.6% | +$1.05M | 0.94% | 39 |
|
|
2019
Q2 | $172M | Buy |
3,644,698
+621,135
| +21% | +$28.7M | 0.91% | 39 |
|
|
2019
Q1 | $146M | Sell |
3,023,563
-43,340
| -1% | -$2.17M | 0.79% | 41 |
|
|
2018
Q4 | $137M | Buy |
3,066,903
+470,941
| +18% | +$24.5M | 0.8% | 42 |
|
|
2018
Q3 | $140M | Sell |
2,595,962
-336,172
| -11% | -$17.2M | 0.68% | 46 |
|
|
2018
Q2 | $143M | Buy |
2,932,134
+58,495
| +2% | +$3.32M | 0.72% | 44 |
|
|
2018
Q1 | $180M | Buy |
2,873,639
+923,179
| +47% | +$63.3M | 0.92% | 39 |
|
|
2017
Q4 | $120M | Buy |
1,950,460
+143,938
| +8% | +$8.9M | 0.59% | 46 |
|
|
2017
Q3 | $121M | Buy |
1,806,522
+747,718
| +71% | +$52.9M | 0.64% | 47 |
|
|
2017
Q2 | $82.5M | Sell |
1,058,804
-499
| -0% | -$37.7K | 0.45% | 56 |
|
|
2017
Q1 | $86.4M | Buy |
+1,059,303
| New | +$83.4M | 0.49% | 55 |
|
Other funds holding CAH
Pzena Investment Management's CAH Position: Q3 2024 in Review
Pzena Investment Management sold out of Cardinal Health (CAH) in Q3 2024, closing a stake of 664,657 shares — an estimated $65.3M sold.
Pzena Investment Management first reported a position in CAH in Q1 2017 and held it in 30 quarters. The position peaked at $202M in Q4 2019. 1,015 funds tracked by Wall St. Rank hold CAH as of Q3 2024.
- Pzena Investment Management reported no remaining Cardinal Health position as of Q3 2024 after selling out during the quarter.
- Pzena Investment Management sold 664,657 Cardinal Health shares in Q3 2024, an estimated $65.3M.
- Pzena Investment Management first reported a position in Cardinal Health in Q1 2017 and held it in 30 quarters.
- Pzena Investment Management's Cardinal Health position peaked at $202M in Q4 2019.
- 1,015 funds tracked by Wall St. Rank held Cardinal Health as of Q3 2024.
Based on Pzena Investment Management's 13F filing for Q3 2024, filed 8 Nov 2024.